Elexacaftor, tezacaftor and ivacaftor: a case of severe rash and approach to desensitisation
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2021-247042
Abstract: We present a case of severe rash following induction of elexacaftor, tezacaftor and ivacaftor (ELX/TEZ/IVA) in a young adult male cystic fibrosis patient. While rash is a commonly reported side effect which resolves in 1–2… read more here.
Keywords: severe rash; rash; case severe; elx tez ... See more keywords